Beta Bionics, Inc.
BBNX
$28.31
-$1.07-3.64%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 88.57M | 78.02M | 69.83M | 65.12M | 53.03M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 88.57M | 78.02M | 69.83M | 65.12M | 53.03M |
| Cost of Revenue | 40.29M | 35.95M | 32.17M | 29.24M | 23.77M |
| Gross Profit | 48.28M | 42.08M | 37.66M | 35.89M | 29.26M |
| SG&A Expenses | 83.00M | 73.79M | 63.80M | 54.96M | 48.41M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 157.16M | 140.55M | 124.27M | 110.38M | 93.62M |
| Operating Income | -68.59M | -62.53M | -54.44M | -45.25M | -40.58M |
| Income Before Tax | -77.84M | -73.37M | -70.96M | -54.76M | -55.50M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -77.84 | -73.37 | -70.96 | -54.76 | -55.50 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -77.84M | -73.37M | -70.96M | -54.76M | -55.50M |
| EBIT | -68.59M | -62.53M | -54.44M | -45.25M | -40.58M |
| EBITDA | -67.33M | -61.31M | -53.27M | -44.10M | -39.37M |
| EPS Basic | -4.36 | -5.50 | -7.48 | -8.61 | -9.02 |
| Normalized Basic EPS | -2.73 | -3.44 | -4.68 | -5.38 | -5.64 |
| EPS Diluted | -4.36 | -5.50 | -7.48 | -8.61 | -9.02 |
| Normalized Diluted EPS | -2.73 | -3.44 | -4.68 | -5.38 | -5.64 |
| Average Basic Shares Outstanding | 124.41M | 87.43M | 50.15M | 25.45M | 24.82M |
| Average Diluted Shares Outstanding | 124.41M | 87.43M | 50.15M | 25.45M | 24.82M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |